Axitinib Impurity 20 | CAS 1443118-72-6 - Request Quote
Axitinib Impurity 20
| SZ CAT No: | SZ-A073041 |
| CAS No | 1443118-72-6 |
| Mol.F. | C29H25N5OS |
| Mol.Wt. | 491.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Axitinib Impurity 20 is chemically (E)-N-methyl-2-((1-(2-(pyridin-2-yl)ethyl)-3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide. Axitinib Impurity 20 is supplied with detailed characterization data compliant with regulatory guideline. Axitinib Impurity 20 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Axitinib .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1443118-72-6
Purchase 1443118-72-6
Order 1443118-72-6
Enquire 1443118-72-6
price of 1443118-72-6
1443118-72-6 Supplier
1443118-72-6 Manufacturer
1443118-72-6 Exporter
buy high quality Axitinib Impurity 20
Purchase Axitinib Impurity 20
Axitinib Impurity 20 suppliers
Axitinib Impurity 20 manufacturers
Axitinib Impurity 20 price
Order Axitinib Impurity 20
Enquire Axitinib Impurity 20
Axitinib Impurity 20 cost
Axitinib Impurity 20 Supplier
Axitinib Impurity 20 Distributor
Axitinib Impurity 20 for Method Validation
Axitinib Reference Standard
Axitinib Impurity 20 for ANDA Filing
Axitinib Impurity 20 for Forced Degradation Studies
Axitinib Impurity 20 Identification Standards
Axitinib Impurity 20 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


